The Latest Cardiac and Vascular News
MINNEAPOLIS, July 12, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced key takeaways from its recent physician-led webinar discussing the benefits of treating fluid overloaded heart failure (HF) patients with Aquadex® ultrafiltration (UF) in the […]
REVERSE-HF will evaluate rehospitalizations and survival when using the Aquadex therapy MINNEAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will evaluate the clinical outcomes and economic value of its Aquadex® therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening […]
Certification will help Nuwellis meet clinical and healthcare economic needs in Europe and make outpatient ultrafiltration treatment more accessible EDEN PRAIRIE, Minn., Sept. 21, 2021 (GLOBE NEWSWIRE) — Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that it has received CE Mark […]
New Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting (NKF) EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) — Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) […]
EDEN PRAIRIE, Minn., Jan. 28, 2021 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using ultrafiltration (UF) in the management of heart failure patients. Panelists […]
EDEN PRAIRIE, Minn., Oct. 27, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped Aquadex™ product to medical facilities in Tennessee and South Carolina to treat critically ill patients suffering […]
EDEN PRAIRIE, Minn., Sept. 10, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from a recent webinar, where Dr. John L. Jefferies discussed the use of precision medicine for the treatment […]
EDEN PRAIRIE, Minn., Sept. 03, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Precision Medicine for the Treatment of Fluid Overload in Patients […]
EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region. Ultrafiltration therapy is now available in 16 countries outside the U.S. Ninety […]
EDEN PRAIRIE, Minn., July 08, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) and RenalSense, Ltd., today announced the signing of a distribution agreement to offer complementary solutions for fluid management. The agreement allows CHF Solutions to market and sell RenalSense’s Clarity RMS™ (real-time monitoring system) in certain U.S. territories. Clarity RMS is […]
